BioPharm News

Aug 03, 2018
By BioPharm International Editors
Researchers at the University of Pennsylvania found that diabetes drugs called thiazolidinediones can promote the metabolism of glutamine to help control disease-causing inflammation.
Aug 03, 2018
By BioPharm International Editors
The companies will collaborate to bring InnoCore Pharmaceuticals’ proprietary SynBiosys biodegradable polymer platform to market.
Aug 03, 2018
By BioPharm International Editors
AuroMedics Pharma issued a voluntary, nationwide recall of two lots of piperacillin and tazobactam for injection, USP 3.375 g due to the presence of particulates identified as glass and silicone material.
Aug 02, 2018
More consistent and reliable production processes are critical for advancing innovative treatments.
Aug 02, 2018
By BioPharm International Editors
The company broke ground on its $200-million, 120,000-sq-ft biomanufacturing plant in West Greenwich, RI.
Aug 02, 2018
By BioPharm International Editors
Stem-cell developer TiGenix has been acquired by Takeda Pharmaceutical for approximately EUR 520 million (US$604 million).
Aug 01, 2018
By BioPharm International Editors
The companies will work together to develop novel gamma delta T-cell receptor therapies in various cancers.
Aug 01, 2018
By BioPharm International Editors
GlaxoSmithKline and 23andMe, a personal genomics and biotechnology company, will partner to research and develop new drugs using human genetics.
Aug 01, 2018
BioPharm International
The agency is asking firms to discuss internal quality metrics efforts as part of the approval process for new medical products.
Jul 28, 2018
By BioPharm International Editors
Novartis is set to partner with MorphoSys and Galapagos in a deal worth up to $1.1 billion to develop and commercialize their joint investigational, fully human, IgG1 monoclonal antibody (mAb) directed against the target IL-17C.
native1_300x100
lorem ipsum